coronavirus update indiaas on : 25 November 2020 05:48 GMT+5:30
COVID Vaccine: Pfizer,BioNTech Seeks Emergency Vaccine Aprroval In US
The US Food and Drug Administration (FDA) said its vaccines committee would meet on December 10 to discuss the request for emergency use authorization.
COVID Vaccine: Pfizer, BioNTech Seeks Emergency Vaccine Approval In US
New Delhi: US biotech giant Pfizer and German partner BioNTech has sought approval Friday to roll out their coronavirus vaccine early, the first step towards relief as surging infections prompt a return to shutdowns that traumatized national and the global economy earlier this years.
This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic.
“Pfizer’s partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA,” health secretary Alex Azar told a press conference Thursday in Washington."I want to assure the American people that the FDA's process and evaluation of the data for a potential Covid-19 vaccine will be as open and transparent as possible."
He said that he could not predict how long the review would take, but the federal government said earlier the final green light would probably come in December.
The Pfizer chief executive Abert Bourla called the filing "a critical milestone in our journey to deliver a COVID-19 vaccine to the world."
The EU Commission president Ursula von der Leyen said the European bloc could also approve both before the end of the year.
"Initially when the virus broke (out), I thought I'll bury 100-200 people and it'll be done. But the current situation is beyond my wildest thoughts," New Delhi gravedigger Mohammed Shamim told AFP.
President Donald Trump's eldest son Don Jr was revealed to have tested positive for the virus earlier this week and was quarantining "at his cabin" without any symptoms.
In the US more than a quarter of million deaths have been reported since the pandemic began, with 1,800 registered on Friday.
The British government said that it had asked its independent medicines regulators to study Pfizer/BioNTech's coronavirus vaccine with a view to an imminent rollout.